NPNikolay A. Pavlov

Nikolay A. Pavlov

*This is an algorithmically generated author record based on publicly available information.

Nikolay A. Pavlov has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative effectiveness of remote and standard outpatient monitoring in achieving hypertension control

    by A. L. Panova, E. A. Zheleznykh, N. A. Pavlov, M. V. Kozhevnikova, Yu. N. Belenkov, А. Л. Панова, Е. А. Железных, Н. А. Павлов, М. В. Кожевникова, Ю. Н. Беленков

    Aim . To compare the effectiveness of remote blood pressure (BP) monitoring using a chatbot with physician feedback in achieving and controlling BP in hypertensive (HTN) patients versus standard outpatient monitoring. Material and methods . The study included 80 patients randomized into two following groups: a remote monitoring (RM) group using a chatbot (n=40) and a control group (n=40). The primary endpoint was achievement of target systolic BP (SBP) and diastolic BP (DBP) control after 3 months. Regular questionnaire completion and symptomatic HTN episodes were also assessed. Results . The median age in the RM group was 68 [66; 70] years, while in the control group — 69,50 [66,75; 73]. The proportion of men was 43% in both groups. In the RM group, three subjects withdrew from the study voluntarily. In the RM group, a significant decrease in SBP was recorded after 3 months (p140 mm Hg was equally common in both groups over the entire follow-up period — 18 (45%) versus 18 patients (45%) (p=0,749). After 3 months, DBP levels significantly decreased in both groups (RM group, p=0,038; control group, pConclusion . Remote BP monitoring using a chatbot and physician feedback is an effective tool for reducing SBP and achieving control in patients with HTN, as evidenced by significant changes in SBP and high patient compliance with RM.

  • Open Access

    Impact of Digital Remote Monitoring on the Optimization of Guideline-Directed Medical Therapy Titration in Heart Failure With Reduced Ejection Fraction

    by M. V. Kozhevnikova, A. V. Emelianov, E. A. Zheleznykh, N. A. Pavlov, N. V. Khabarova, Yu. N. Belenkov

    Aim   To evaluate the impact of digital remote monitoring on the effectiveness of intensive dose titration for guideline-directed medical therapy (GDMT) in patients with heart failure with reduced ejection fraction (HFrEF) for the achievement of target doses and the reduction of decompensated heart failure rate and all-cause mortality. Materials and methods The study utilized vital sign monitoring via a personal messenger-based questionnaire (chatbot) and weekly therapy optimization recommendations for 6 weeks following hospital discharge. The control group received standard outpatient care. The study is registered at ClinicalTrials.gov (NCT06304753). Between October 27, 2023, and December 27, 2024, 66 HFrEF patients were enrolled and randomized into a remote monitoring (RM) group (n=33) and a standard care (SC) group (n=33). The 6-week observation period was completed by 26 patients in the RM group and all 33 patients in the SC group. Results   The RM group showed a statistically significant increase in the dosages of GDMT and a higher number of patients reaching target doses. In contrast, the SC group showed either no changes in therapy or a decrease in dosages of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitor (87.5 [50; 100]% vs. 25 [12.5; 25]%, pConclusion The study confirmed the feasibility, efficacy, and safety of intensive titration of guideline-directed medical therapy for chronic heart failure using remote monitoring.

  • Effectiveness of a chatbot in remote monitoring of arterial hypertension in patients over 65 years of age (an open, randomized, controlled study)

    by A. L. Panova, E. A. Zheleznykh, N. A. Pavlov, M. V. Kozhevnikova, K. A. Eruslanova, A. Y. Shchedrina, L. Y. Alibekova, S. R. Gilyarevskiy, Y. N. Belenkov

    BACKGROUND. Improving treatment adherence in elderly patients with hypertension remains an important challenge in modern cardiology. One promising approach is the use of remote monitoring technologies. OBJECTIVE. The objective of this study was to evaluate the feasibility of remote monitoring and its impact on adherence to blood pressure measurement and data transmission via a chatbot in patients with hypertension over 65 years of age. MATERIALS AND METHODS. This open-label, randomized, controlled trial included 95 patients aged ≥65 years who were randomized into 2 groups: 1) remote monitoring (RM) (n = 50; median age 70 years; 27 % men) and 2) control (n = 45; median age 71 years; 40 % men). The RM group utilized remote monitoring, which included daily patient surveys via a chatbot in a messenger. In case of systolic blood pressure (SBP) decrease RESULTS. After 3 months, 45 patients in the UN group and 45 patients in the control group completed the study. An increase in SBP above 150 mm Hg during home measurement was significantly more frequent in the control group (UN 6 (13 %); control group 20 (44 %); p = 0.001). The absolute reduction in SBP in both groups was statistically significant. In the UN group, the absolute reduction in SBP was 7.5 mm Hg (p < 0.001), in the control group 5 mm Hg (p = 0.003). Adherence to the chatbot and blood pressure data transmission for more than 50 % of the observation time was observed in 43 patients (95 %), and more than 75 % in 27 patients (60 %). Symptomatic hypotension was observed in 22 patients (49 %) in the remote monitoring group. CONCLUSION. Digital platforms for remote monitoring can be effective in hypertension management, promoting increased engagement in the treatment process in patients over 65 years of age. Patient adherence for more than 50 % of the observation time via messenger was 95 %.


  • Open Access

    Six-Month Remote Monitoring of Patients With Chronic Heart Failure Using Messaging Applications on Smartphones

    by Elena Zheleznykh, Anastasia Panova, Aleksei Emelianov, Daria Kutsakina, Andrei Nartov, Valeria Nartova, Nikolay Pavlov, Yuri Belenkov, Maria Kozhevnikova

    Background: Patients with chronic heart failure (HF) require outpatient monitoring after hospital discharge. The ability to use a smartphone with a personal messaging application may help. Objectives: Tis study aimed to investigate the feasibility of remote monitoring and evaluate its impact on treatment adherence and prognosis in patients with HF. Methods: A total of 100 patients were enrolled in the study: 57 patients in the mHealth group and 43 in the control group. The observation period lasted six months. [...] Abstract Background: Patients with chronic heart failure (HF) require outpatient monitoring after hospital discharge. The ability to use a smartphone with a personal messaging application may help. Objectives: Tis study aimed to investigate the feasibility of remote monitoring and evaluate its impact on treatment adherence and prognosis in patients with HF. Methods: A total of 100 patients were enrolled in the study: 57 patients in the mHealth group and 43 in the control group. The observation period lasted six months.


  • Open Access

    The Contribution of Digital Remote Monitoring to Improving the Effectiveness of Treatment in Patients with Chronic Heart Failure with Reduced Ejection Fraction: data after a 6-week follow-up period (Preprint)

    by Maria Kozhevnikova, Aleksei Emelianov, Elena Zheleznykh, Nikolay Pavlov, Natalia Khabarova, Yuri Belenkov

    BACKGROUND The main strategy for the management of heart failure (HF) patients with reduced ejection fraction is guideline-directed medical therapy (GDMT). Remote GDMT optimization using digital monitoring and guideline support appears to be a promising method. Therefore, the Contribution of Digital Remote Monitoring to Improving the Effectiveness of Treatment in Patients with Chronic Heart Failure with Reduced Ejection Fraction (BOT-IMPROVE-HF) was conducted. OBJECTIVE The aim of the study is to assess the effectiveness of rapid titration of GDMT to reach the target doses and reduce the combined endpoint of all-cause mortality and HF decompensation. METHODS This research introduces a multifaceted approach consisting of the following components: vital signs data sharing using a questionnaire via a free mobile messaging tool (chatbot), and weekly digital guideline recommendations to optimize therapy weekly for 6 weeks. RESULTS A total of 66 patients with HF with reduced ejection fraction were randomized between the remote monitoring (RM) group and the usual care (UC) group between 27 October 2023 and 27 December 2024. Thirty-three patients were included in each group. Twenty-six patients in the RM group and all patients in the UC group completed the 6-week follow-up period and were taken for primary endpoint analysis. There was a significant increase in the median dose of GDMT in the RM group, while there were no changes or were down-titrations in the UC group [angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor–neprilysin inhibitors P < 0.001*); β-blockers (P = 0.0001*); mineralocorticoid receptor antagonists (P = 0.005*)]. The doses of diuretics were significantly reduced in the RM group (P = 0.01*) and did not change in the UC group after 6 weeks (P = 0.9). HF decompensation and mortality rates were higher in the UC group than in the RM group (16 (2 mortality, 14 decompensations) vs 2 (0 mortality, 2 decompensations), P = 0.0003*). No difference was observed between the RM group and the UC group after 6 weeks in systolic blood pressure (P = 0.9), heart rate (P = 0.06), estimated glomerular filtration rate (P = 0.22) and potassium level (P = 0.33). CONCLUSIONS The article shows the results of a 6-week follow-up period. The BOT-IMPROVE-HF trial met its primary outcome and achieved a higher dose of GDMT in the RM group. The intervention was safe, and no treatment complications were registered. CLINICALTRIAL ClinicalTrials.gov NCT06304753

  • The use of computer vision for the mammography preventive research

    by K.M. Arzamasov, Yu.A. Vasilev, A.V. Vladzymyrskyy, O.V. Omelyanskaya, T.M. Bobrovskaya, S.S. Semenov, S.F. Chetverikov, Yu.S. Kirpichev, N.A. Pavlov, A.E. Andreychenko

    Computer vision algorithms based on artificial intelligence for diagnostic radiology are rapidly developing. For effective implementation in clinical practice, it is necessary to determine the capabilities and limitations of these algorithms. Objective. To evaluate the threshold values of the quality metrics of computer vision artificial intelligence-based algorithms for the analysis of mammographic examinations in comparison with the diagnostic accuracy of the radiologist. Materials and methods. The study involving a group of radiologists was performed on the «Web-based Radiology Evaluation Platform» on a labeled dataset from mammography studies. The same dataset was sent to 5 artificial intelligence (AI)-based algorithms. Metrics of diagnostic accuracy of an average radiologist and each AI service were obtained using ROC analysis. Results. The diagnostic accuracy of radiologists (AUC) significantly exceeded the indices of 2 out of 5 AI services. None of the AI services in the study significantly exceeded the AUC of the «average» radiologist. The diagnostic accuracy metrics of the «average» radiologist were: AUC 0.928 (95% CI 0.883—0.976), sensitivity 0.792 (95% CI 0.677—0.907), specificity 0.940 (95% CI 0.874—1.000). Conclusion. When deciding on the implementation of artificial intelligence-based computer vision algorithms for preventive mammography, the minimum AUC value obtained for the “average” radiologist should be used (>0.88).


  • Open Access

    Nouveautés dans la prise en charge de l’asthme

    by Jörg D. Leuppi, Pierre-Olivier Bridevaux, Florian Charbonnier, Christian Clarenbach, Hans-Werner Duchna, Pietro Gianella, Anja Jochmann, Lukas Kern, Franca Meyer, Nikolay Pavlov, et al.

    Les nouvelles recommandations GINA (Global Initiative for Asthma) modifient radicalement la prise en charge des patients asthmatiques pour le médecin de...


  • Neues in der Asthma-Grundversorgung

    by Jörg D. Leuppi, Pierre-Olivier Bridevaux, Florian Charbonnier, Christian Clarenbach, Hans-Werner Duchna, Pietro Gianella, Anja Jochmann, Lukas Kern, Franca Meyer, Nikolay Pavlov, et al.

    Zusammenfassung. Für die Allgemeinpraktikerin und den Allgemeinpraktiker gibt es wichtige Neuerungen in der Asthmabehandlung, da sich die internationalen Empfehlungen auf Basis der Global Initiative for Asthma (GINA) geändert haben. Für die Stufe 1 wird der alleinige Einsatz kurzwirksamer β2-Agonisten (SABA) ohne inhalatives Kortikosteroid (ICS) aufgrund der mangelnden Wirksamkeit und Sicherheit nicht mehr empfohlen, sondern stattdessen niedrig dosiertes ICS-Formoterol bei Bedarf. Bei schwerem, unkontrolliertem Asthma der Stufe 5 wird der Einsatz von biologischen Therapien, wie z.B. Interleukin-Antikörpern, empfohlen. Weisen Asthma-Kranke gleichzeitig auch Symptome einer chronisch-obstruktiven Lungenkrankheit (COPD) auf, sollten sie mit einer ICS-enthaltenden Therapie behandelt werden. Die Empfehlungen der GINA bleiben auch während der Corona-Pandemie unverändert gültig. Aktuelle Verschreibungsdaten der Schweiz belegen, dass sowohl SABA als auch orale Kortikosteroide (OCS) noch eine grosse Rolle in der Asthmabehandlung spielen und die GINA-Empfehlungen noch nicht ausreichend umgesetzt wurden.


  • Open Access

    Reference medical datasets (MosMedData) for independent external evaluation of algorithms based on artificial intelligence in diagnostics

    by Nikolay A. Pavlov, Anna E. Andreychenko, Anton V. Vladzymyrskyy, Anush A. Revazyan, Yury S. Kirpichev, Sergey P. Morozov

    The article describes a novel approach to creating annotated medical datasets for testing artificial intelligence-based diagnostic solutions. Moreover, there are four stages of dataset formation described: planning, selection of initial data, marking and verification, and documentation. There are also examples of datasets created using the described methods. The technique is scalable and versatile, and it can be applied to other areas of medicine and healthcare that are being automated and developed using artificial intelligence and big data technologies.


  • Open Access

    MosMedData: data set of 1110 chest CT scans performed during the COVID-19 epidemic

    by Sergey P. Morozov, Anna E. Andreychenko, Ivan A. Blokhin, Pavel B. Gelezhe, Anna P. Gonchar, Alexander E. Nikolaev, Nikolay A. Pavlov, Valeria Yu. Chernina, Victor A. Gombolevskiy, Гомболевский Виктор Александрович

    With the ongoing COVID-19 pandemic decreasing availability of polymerase chain reaction with reverse transcription and the snowballing growth of medical imaging, especially the number of chest computed tomography (CT) scans being performed, methods to augment and automate the image analysis, increasing productivity and minimizing human error are of particular importance. The creation of high-quality datasets is essential for the development and validation of artificial intelligence algorithms. Such technologies have sufficient accuracy in diagnosing COVID-19 in medical imaging. The presented large-scale dataset contains anonymized human CT scans with COVID-19 features as well as normal studies. Some studies were tagged by radiologists using binary pixel masks of regions of interest (e.g., characteristic areas of consolidation and ground-glass opacities). CT data were acquired between March 1, 2020, and April 25, 2020, and provided by municipal hospitals in Moscow, Russia. The presented dataset is licensed under Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND 3.0).